EUVIMEDEUVIMED entdecken
Crossref

Human Adipose-Derived Mesenchymal Stem Cell-Based Microspheres Ameliorate Atherosclerosis Progression In Vitro

Shaojie Yang iD, Xiong Xiao, Ziwei Huang, Qingyun Chen, Chenxi Li, Chuan Niu, Yuchu Yang, Liping Yang, Bing-Mei Zhu, Li Feng iD

Stem Cells and Development · 2023-06 · 32 (11-12) · 314-330

DOI: 10.1089/scd.2022.0287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells and Development, online erschienen am 02.06.2023. Verfasst von Shaojie Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Atherosclerosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis (AS) is a chronic inflammatory disease associated with lipid deposition, which could be converted into acute clinical events by thrombosis or plaque rupture. Adipose-derived mesenchymal stem cell (ADSC)-encapsulated repair units could be an effective cure for the treatment of AS patients. In this study, we encapsulate human adipose-derived mesenchymal stem cells (hADSCs) in collagen microspheres to fabricate stem cell repair units. Besides, we show that encapsulation in collagen microspheres and cultured in vitro for 14 days maintain the viability and stemness of hADSCs. Moreover, we generate AS progression model and niche in vitro by combining hyperlipemia serum of AS patients with AS cell models. We further systematically demonstrate that hADSC-based microspheres could ameliorate AS progression by inhibiting oxidative stress injury, cell apoptosis, endothelial dysfunction, inflammation, and lipid accumulation. In addition, we perform transcriptomic analysis and functional studies to demonstrate how hADSCs (three dimensional cultured in microspheres) respond to AS niche compared with healthy microenvironment. These findings reveal a role for ADSC-based microspheres in the treatment of AS and provide new ideas for stem cell therapy in cardiovascular disease. The results may have implications for improving the efficiency of hADSC therapies by illuminating the mechanisms of hADSCs exposed in special pathological niche.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsAtherosclerosisHumansMicrospheresAdipose TissueLipids

Stichwörter der Autor:innen

adipose-derived mesenchymal stem cells (ADSCs)atherosclerosis (AS)cell encapsulationcell microspherestem cell therapy

Substanzen

Lipids

Autor:innen und Institutionen

  • Regenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, China.
  • Department of Clinical Laboratory, the Sixth People's Hospital of Chengdu, Chengdu, China.

ORCID-Profile: Shaojie Yang, Li Feng

Zitieren

APA

Yang, S., Xiao, X., Huang, Z., Chen, Q., Li, C., Niu, C., Yang, Y., Yang, L., Zhu, B. M., & Feng, L. (2023). Human Adipose-Derived Mesenchymal Stem Cell-Based Microspheres Ameliorate Atherosclerosis Progression In Vitro. Stem Cells and Development, 32(11-12), 314-330. https://doi.org/10.1089/scd.2022.0287

Vancouver

Yang S, Xiao X, Huang Z, Chen Q, Li C, Niu C, et al. Human Adipose-Derived Mesenchymal Stem Cell-Based Microspheres Ameliorate Atherosclerosis Progression In Vitro. Stem Cells and Development. 2023;32(11-12):314-330. doi:10.1089/scd.2022.0287

BibTeX
@article{Yang2023,
  author = {Yang, Shaojie and Xiao, Xiong and Huang, Ziwei and Chen, Qingyun and Li, Chenxi and Niu, Chuan and Yang, Yuchu and Yang, Liping and Zhu, Bing-Mei and Feng, Li},
  title = {Human Adipose-Derived Mesenchymal Stem Cell-Based Microspheres Ameliorate Atherosclerosis Progression In Vitro},
  journal = {Stem Cells and Development},
  year = {2023},
  volume = {32},
  number = {11-12},
  pages = {314--330},
  doi = {10.1089/scd.2022.0287}
}
Kostenlos starten →